Concepedia

Miriam M. Yeung

MM

9

Publications

1.2K

Citations

9

H-Index

1990

Active since

Affiliations

Peter MacCallum Cancer Centre(Current)

The University of Melbourne

Monash University

GlaxoSmithKline (United States)

Walter and Eliza Hall Institute of Medical Research

Miriam M. Yeung is an author at Peter MacCallum Cancer Centre specializing in medicine, cell biology, and radiation oncology.

ORCID

Top concepts

Publications per year

1990–2022

9

Publications

9

Selective targeting of BD1 and BD2 of the BET proteins in cancer and immunoinflammation

Omer Gilan, Inmaculada Rioja, Kathy Knezevic et al. · Science · 2020 · 411 citations · Full text

Targeting enhancer switching overcomes non-genetic drug resistance in acute myeloid leukaemia

Charles C. Bell, Katie Fennell, Yih-Chih Chan et al. · Nature Communications · 2019 · 175 citations · Full text

HBO1 is required for the maintenance of leukaemia stem cells

Laura MacPherson, Juliana Anokye, Miriam M. Yeung et al. · Nature · 2019 · 170 citations · Full text

, , +7

A Phase Ib Dose-Escalation and Expansion Study of the BCL2 Inhibitor Venetoclax Combined with Tamoxifen in ER and BCL2–Positive Metastatic Breast Cancer

Sheau Wen Lok, James R. Whittle, François Vaillant et al. · Cancer Discovery · 2019 · 143 citations · Full text

HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults

Nila J. Dharan, Paul Yeh, Mark Bloch et al. · Nature Medicine · 2021 · 98 citations

, , +7

Rows per page

1–5 of 9